Home Compare PFE
Peer Analysis

Pfizer Inc. — Peer Companies & Stock Comparisons

Pfizer Inc.'s functional peer companies ranked by peer score — growth, valuation, profitability and stability compared.

Compare PFE with peers
Comparison PFE peer score
Pfizer Inc. vs Man Group Plc
49 Compare →
Pfizer Inc. vs Hologic, Inc.
63 Compare →
Pfizer Inc. vs DuPont de Nemours, Inc.
34 Compare →
Pfizer Inc. vs Fortive Corporation
36 Compare →
Pfizer Inc. vs Bolloré SE
26 Compare →
Pfizer Inc. vs Antero Resources Corporation
58 Compare →
Pfizer Inc. vs VEND.OL
38 Compare →
Pfizer Inc. vs Qiagen N.V.
46 Compare →
Pfizer Inc. vs Allfunds Group plc
46 Compare →
Pfizer Inc. vs Revvity, Inc.
29 Compare →

Full PFE analysis in AssetNext

View the complete Pfizer Inc. report including all peer dimensions.

Open in AssetNext →

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.